PeterRussellKoweyMD
Cardiology • Wynnewood, PAAdult Congenital Heart Disease, Cardiac Electrophysiology
Professor of Medicine, Thomas Jefferson University
Are you Dr. Kowey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 E Lancaster Ave
J.D Lankenau Pavilion, Mezzanine
Wynnewood, PA 19096Phone+1 484-476-1000Fax+1 484-476-9000
Summary
- Dr. Peter Kowey, MD is a cardiologist in Wynnewood, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is a Professor of Medicine at Thomas Jefferson University.
Education & Training
Perelman School of Medicine at the University of PennsylvaniaClass of 1975
Certifications & Licensure
PA State Medical License 1976 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry.Max J Jason, Lucas N Marzec, Jonathan P Piccini, Peter Shrader, Karen S Pieper
International Journal of Cardiology. 2025-02-15 - 3 citationsMilvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.Sneha S Jain, Kenneth W Mahaffey, Karen S Pieper, Wataru Shimizu, Tatjana Potpara
American Heart Journal. 2024-11-01 - An international physician survey of current ablation practices in atrial fibrillation: An AIM-AF substudy.Sanjeev Saksena, April Slee, Jose L Merino, Andreas Goette, Giuseppe Boriani
Heart Rhythm. 2024-10-24
Press Mentions
Ablation Is Safe and Effective in Treating Atrial Fibrillation, Research Guided by Main Line Health Expert ShowsMarch 8th, 2023- Penn Medicine Cardiologist Is Honored with 2023 Edward S. Cooper, MD AwardJanuary 26th, 2023
- Anthos Therapeutics Announces That Abelacimab Has Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with Atrial FibrillationSeptember 8th, 2022
- Join now to see all
